Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Molecular Autism
Published in: Molecular Autism 1/2022

Open Access 01-12-2022 | Autism Spectrum Disorder | Research

Early life sleep disruption potentiates lasting sex-specific changes in behavior in genetically vulnerable Shank3 heterozygous autism model mice

Authors: Julia S. Lord, Sean M. Gay, Kathryn M. Harper, Viktoriya D. Nikolova, Kirsten M. Smith, Sheryl S. Moy, Graham H. Diering

Published in: Molecular Autism | Issue 1/2022

Login to get access

Abstract

Background

Patients with autism spectrum disorder (ASD) experience high rates of sleep disruption beginning early in life; however, the developmental consequences of this disruption are not understood. We examined sleep behavior and the consequences of sleep disruption in developing mice bearing C-terminal truncation mutation in the high-confidence ASD risk gene SHANK3 (Shank3ΔC). We hypothesized that sleep disruption may be an early sign of developmental divergence, and that clinically relevant Shank3WT/ΔC mice may be at increased risk of lasting deleterious outcomes following early life sleep disruption.

Methods

We recorded sleep behavior in developing Shank3ΔC/ΔC, Shank3WT/ΔC, and wild-type siblings of both sexes using a noninvasive home-cage monitoring system. Separately, litters of Shank3WT/ΔC and wild-type littermates were exposed to automated mechanical sleep disruption for 7 days prior to weaning (early life sleep disruption: ELSD) or post-adolescence (PASD) or undisturbed control (CON) conditions. All groups underwent standard behavioral testing as adults.

Results

Male and female Shank3ΔC/ΔC mice slept significantly less than wild-type and Shank3WT/ΔC siblings shortly after weaning, with increasing sleep fragmentation in adolescence, indicating that sleep disruption has a developmental onset in this ASD model. ELSD treatment interacted with genetic vulnerability in Shank3WT/ΔC mice, resulting in lasting, sex-specific changes in behavior, whereas wild-type siblings were largely resilient to these effects. Male ELSD Shank3WT/ΔC subjects demonstrated significant changes in sociability, sensory processing, and locomotion, while female ELSD Shank3WT/ΔC subjects had a significant reduction in risk aversion. CON Shank3WT/ΔC mice, PASD mice, and all wild-type mice demonstrated typical behavioral responses in most tests.

Limitations

This study tested the interaction between developmental sleep disruption and genetic vulnerability using a single ASD mouse model: Shank3ΔC (deletion of exon 21). The broader implications of this work should be supported by additional studies using ASD model mice with distinct genetic vulnerabilities.

Conclusion

Our study shows that sleep disruption during sensitive periods of early life interacts with underlying genetic vulnerability to drive lasting and sex-specific changes in behavior. As individuals progress through maturation, they gain resilience to the lasting effects of sleep disruption. This work highlights developmental sleep disruption as an important vulnerability in ASD susceptibility.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Veatch OJ, Sutcliffe JS, Warren ZE, Keenan BT, Potter MH, Malow BA. Shorter sleep duration is associated with social impairment and comorbidities in ASD. Autism Res. 2017;10(7):1221–38.PubMedPubMedCentralCrossRef
4.
MacDuffie KE, Munson J, Greenson J, Ward TM, Rogers SJ, Dawson G, et al. Sleep problems and trajectories of restricted and repetitive behaviors in children with neurodevelopmental disabilities. J Autism Dev Disord. 2020;50(11):3844–56.PubMedCrossRef
5.
MacDuffie KE, Shen MD, Dager SR, Styner MA, Kim SH, Paterson S, et al. Sleep onset problems and subcortical development in infants later diagnosed with autism spectrum disorder. Am J Psychiatry. 2020;177(6):518–25.PubMedPubMedCentralCrossRef
6.
Verhoeff ME, Blanken LME, Kocevska D, Mileva-Seitz VR, Jaddoe VWV, White T, et al. The bidirectional association between sleep problems and autism spectrum disorder: a population-based cohort study. Mol Autism. 2018;9:8.PubMedPubMedCentralCrossRef
7.
Jones CE, Opel RA, Kaiser ME, Chau AQ, Quintana JR, Nipper MA, et al. Early-life sleep disruption increases parvalbumin in primary somatosensory cortex and impairs social bonding in prairie voles. Sci Adv. 2019;5(1):eaav5188.PubMedPubMedCentralCrossRef
8.
Kayser MS, Yue Z, Sehgal A. A critical period of sleep for development of courtship circuitry and behavior in Drosophila. Science. 2014;344(6181):269–74.PubMedPubMedCentralCrossRef
9.
10.
11.
Roffwarg HP, Muzio JN, Dement WC. Ontogenetic development of the human sleep-dream cycle. Science. 1966;152(3722):604–19.PubMedCrossRef
12.
Rensing N, Moy B, Friedman JL, Galindo R, Wong M. Longitudinal analysis of developmental changes in electroencephalography patterns and sleep-wake states of the neonatal mouse. PLoS One. 2018;13(11):e0207031.PubMedPubMedCentralCrossRef
13.
14.
Blumberg MS, Coleman CM, Johnson ED, Shaw C. Developmental divergence of sleep-wake patterns in orexin knockout and wild-type mice. Eur J Neurosci. 2007;25(2):512–8.PubMedPubMedCentralCrossRef
15.
16.
Alcantara S, Ferrer I, Soriano E. Postnatal development of parvalbumin and calbindin D28K immunoreactivities in the cerebral cortex of the rat. Anat Embryol (Berl). 1993;188(1):63–73.CrossRef
17.
del Rio JA, de Lecea L, Ferrer I, Soriano E. The development of parvalbumin-immunoreactivity in the neocortex of the mouse. Brain Res Dev Brain Res. 1994;81(2):247–59.PubMedCrossRef
18.
Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2007;39(1):25–7.PubMedCrossRef
19.
20.
Bro D, O'Hara R, Primeau M, Hanson-Kahn A, Hallmayer J, Bernstein JA. Sleep disturbances in individuals with phelan-mcdermid syndrome: correlation with caregivers' sleep quality and daytime functioning. Sleep. 2017;40(2).
21.
22.
Speed HE, Kouser M, Xuan Z, Reimers JM, Ochoa CF, Gupta N, et al. Autism-Associated Insertion Mutation (InsG) of Shank3 Exon 21 causes impaired synaptic transmission and behavioral deficits. J Neurosci. 2015;35(26):9648–65.PubMedPubMedCentralCrossRef
23.
Jaramillo TC, Speed HE, Xuan Z, Reimers JM, Liu S, Powell CM. Altered striatal synaptic function and abnormal behaviour in Shank3 Exon4-9 deletion mouse model of autism. Autism Res. 2016;9(3):350–75.PubMedCrossRef
24.
Kouser M, Speed HE, Dewey CM, Reimers JM, Widman AJ, Gupta N, et al. Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission. J Neurosci. 2013;33(47):18448–68.PubMedPubMedCentralCrossRef
25.
Drapeau E, Riad M, Kajiwara Y, Buxbaum JD. Behavioral Phenotyping of an Improved Mouse Model of Phelan-McDermid Syndrome with a Complete Deletion of the Shank3 Gene. eNeuro. 2018;5(3).
26.
Matas E, Maisterrena A, Thabault M, Balado E, Francheteau M, Balbous A, et al. Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model. Mol Autism. 2021;12(1):2.PubMedPubMedCentralCrossRef
27.
Ingiosi AM, Schoch H, Wintler T, Singletary KG, Righelli D, Roser LG, et al. Shank3 modulates sleep and expression of circadian transcription factors. Elife. 2019;8.
28.
Zhou Y, Kaiser T, Monteiro P, Zhang X, Van der Goes MS, Wang D, et al. Mice with Shank3 mutations associated with ASD and schizophrenia display both shared and distinct defects. Neuron. 2016;89(1):147–62.PubMedCrossRef
29.
Mang GM, Nicod J, Emmenegger Y, Donohue KD, O’Hara BF, Franken P. Evaluation of a piezoelectric system as an alternative to electroencephalogram/ electromyogram recordings in mouse sleep studies. Sleep. 2014;37(8):1383–92.PubMedPubMedCentralCrossRef
30.
Donohue KD, Medonza DC, Crane ER, O’Hara BF. Assessment of a non-invasive high-throughput classifier for behaviours associated with sleep and wake in mice. Biomed Eng Online. 2008;7:14.PubMedPubMedCentralCrossRef
31.
Flores AE, Flores JE, Deshpande H, Picazo JA, Xie XS, Franken P, et al. Pattern recognition of sleep in rodents using piezoelectric signals generated by gross body movements. IEEE Trans Biomed Eng. 2007;54(2):225–33.PubMedCrossRef
32.
Sinton CM, Kovakkattu D, Friese RS. Validation of a novel method to interrupt sleep in the mouse. J Neurosci Methods. 2009;184(1):71–8.PubMedCrossRef
33.
Li Y, Panossian LA, Zhang J, Zhu Y, Zhan G, Chou YT, et al. Effects of chronic sleep fragmentation on wake-active neurons and the hypercapnic arousal response. Sleep. 2014;37(1):51–64.PubMedPubMedCentralCrossRef
34.
Jimenez JA, Ptacek TS, Tuttle AH, Schmid RS, Moy SS, Simon JM, et al. Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life. Mol Autism. 2020;11(1):74.PubMedPubMedCentralCrossRef
35.
Kercmar J, Budefeld T, Grgurevic N, Tobet SA, Majdic G. Adolescent social isolation changes social recognition in adult mice. Behav Brain Res. 2011;216(2):647–51.PubMedCrossRef
36.
Kolevzon A, Delaby E, Berry-Kravis E, Buxbaum JD, Betancur C. Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature. Mol Autism. 2019;10:50.PubMedPubMedCentralCrossRef
37.
Lai MC, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry. 2015;54(1):11–24.PubMedPubMedCentralCrossRef
38.
Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? PLoS Biol. 2011;9(6):e1001081.PubMedPubMedCentralCrossRef
39.
40.
Zhu Y, Zhan G, Fenik P, Brandes M, Bell P, Francois N, et al. Chronic sleep disruption advances the temporal progression of tauopathy in P301S mutant mice. J Neurosci. 2018;38(48):10255–70.PubMedPubMedCentralCrossRef
41.
42.
Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004;3(5):287–302.PubMedCrossRef
43.
Yang M, Silverman JL, Crawley JN. Automated three-chambered social approach task for mice. Curr Protoc Neurosci. 2011;Chapter 8:Unit 8–26.
44.
Lin R, Learman LN, Bangash MA, Melnikova T, Leyder E, Reddy SC, et al. Homer1a regulates Shank3 expression and underlies behavioral vulnerability to stress in a model of Phelan-McDermid syndrome. Cell Rep. 2021;37(7):110014.PubMedCrossRef
45.
Ehlen JC, Jones KA, Pinckney L, Gray CL, Burette S, Weinberg RJ, et al. Maternal Ube3a loss disrupts sleep homeostasis but leaves circadian rhythmicity largely intact. J Neurosci. 2015;35(40):13587–98.PubMedPubMedCentralCrossRef
46.
Johnston MV, Ammanuel S, O’Driscoll C, Wozniak A, Naidu S, Kadam SD. Twenty-four hour quantitative-EEG and in-vivo glutamate biosensor detects activity and circadian rhythm dependent biomarkers of pathogenesis in Mecp2 null mice. Front Syst Neurosci. 2014;8:118.PubMedPubMedCentralCrossRef
47.
Sare RM, Harkless L, Levine M, Torossian A, Sheeler CA, Smith CB. Deficient sleep in mouse models of fragile × syndrome. Front Mol Neurosci. 2017;10:280.PubMedPubMedCentralCrossRef
48.
49.
Zhou Y, Lai CSW, Bai Y, Li W, Zhao R, Yang G, et al. REM sleep promotes experience-dependent dendritic spine elimination in the mouse cortex. Nat Commun. 2020;11(1):4819.PubMedPubMedCentralCrossRef
50.
51.
Yang G, Gan WB. Sleep contributes to dendritic spine formation and elimination in the developing mouse somatosensory cortex. Dev Neurobiol. 2012;72(11):1391–8.PubMedPubMedCentralCrossRef
52.
Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse? Science. 2003;302(5646):826–30.PubMedCrossRef
53.
Volk L, Chiu SL, Sharma K, Huganir RL. Glutamate synapses in human cognitive disorders. Annu Rev Neurosci. 2015;38:127–49.PubMedCrossRef
54.
Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N, et al. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism. 2010;1(1):15.PubMedPubMedCentralCrossRef
55.
Gai X, Xie HM, Perin JC, Takahashi N, Murphy K, Wenocur AS, et al. Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry. 2012;17(4):402–11.PubMedCrossRef
56.
Tatavarty V, Torrado Pacheco A, Groves Kuhnle C, Lin H, Koundinya P, Miska NJ, et al. Autism-associated Shank3 is essential for homeostatic compensation in rodent V1. Neuron. 2020;106(5):769–77 e4.
57.
Wood-Downie H, Wong B, Kovshoff H, Mandy W, Hull L, Hadwin JA. Sex/Gender Differences in Camouflaging in Children and Adolescents with Autism. J Autism Dev Disord. 2021;51(4):1353–64.PubMedCrossRef
58.
Kreiser NL, White SW. ASD in females: are we overstating the gender difference in diagnosis? Clin Child Fam Psychol Rev. 2014;17(1):67–84.PubMedCrossRef
59.
Zhou Y, Sharma J, Ke Q, Landman R, Yuan J, Chen H, et al. Atypical behaviour and connectivity in SHANK3-mutant macaques. Nature. 2019;570(7761):326–31.PubMedCrossRef
60.
Wintler T, Schoch H, Frank MG, Peixoto L. Sleep, brain development, and autism spectrum disorders: insights from animal models. J Neurosci Res. 2020;98(6):1137–49.PubMedPubMedCentralCrossRef
Metadata
Title
Early life sleep disruption potentiates lasting sex-specific changes in behavior in genetically vulnerable Shank3 heterozygous autism model mice
Authors
Julia S. Lord
Sean M. Gay
Kathryn M. Harper
Viktoriya D. Nikolova
Kirsten M. Smith
Sheryl S. Moy
Graham H. Diering
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Molecular Autism / Issue 1/2022
Electronic ISSN: 2040-2392
DOI
https://doi.org/10.1186/s13229-022-00514-5

Other articles of this Issue 1/2022

Molecular Autism 1/2022 Go to the issue

Research

Altered frontal connectivity as a mechanism for executive function deficits in fragile X syndrome

Research

Autism traits outweigh alexithymia traits in the explanation of mentalising performance in adults with autism but not in adults with rejected autism diagnosis

Research

Inter-individual heterogeneity of functional brain networks in children with autism spectrum disorder

Research

Autism and chronic ill health: an observational study of symptoms and diagnoses of central sensitivity syndromes in autistic adults

Research

White matter microstructural and morphometric alterations in autism: implications for intellectual capabilities

Research

Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis